GlobeNewswire: Biomerica, Inc. Contains the last 10 of 177 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T15:51:52ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/28/2853981/0/en/Biomerica-InFoods-IBS-Data-to-be-Presented-at-the-Upcoming-Digestive-Disease-Week-DDW-2024-Conference.html?f=22&fvtc=4&fvtv=37268Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference2024-03-28T12:19:00Z<![CDATA[IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company at the forefront of innovative gastroenterology solutions, proudly announces that data from collaborators at the University of Michigan utilizing its groundbreaking inFoods IBS technologies will be presented in the IBS Clinical Session at the 2024 Digestive Disease Week (DDW) Annual Meeting in Washington DC. DDW is renowned as the world's premier scientific and clinical meeting for digestive disease health care professionals.]]>https://www.globenewswire.com/news-release/2024/02/21/2832740/0/en/Diagnostics-Industry-Leader-Gary-Huff-Appointed-to-Biomerica-Strategic-Advisory-Board.html?f=22&fvtc=4&fvtv=37268Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board2024-02-21T13:19:00Z<![CDATA[Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare]]>https://www.globenewswire.com/news-release/2024/01/23/2814070/0/en/Diagnostics-Industry-Leader-Jack-Kenny-Appointed-as-Chairman-of-the-Board-at-Biomerica.html?f=22&fvtc=4&fvtv=37268Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica2024-01-23T13:19:00Z<![CDATA[IRVINE, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Jack Kenny, former CEO and board member of Meridian Bioscience, Inc., to serve as the Chairman of the Board of Directors of Biomerica. Mr. Zack Irani will continue to serve as CEO. Mr. Kenny joined the Biomerica Board of Directors in August 2023 as an independent director.]]>https://www.globenewswire.com/news-release/2024/01/16/2809870/0/en/Biomerica-Reports-Second-Quarter-2024-Financial-Results.html?f=22&fvtc=4&fvtv=37268Biomerica Reports Second Quarter 2024 Financial Results2024-01-16T13:19:00Z<![CDATA[IRVINE, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the second quarter of fiscal 2024 ended November 30, 2023.]]>https://www.globenewswire.com/news-release/2023/12/18/2797746/0/en/Biomerica-Received-US-FDA-510-k-Clearance-for-Their-Hp-Detect-ELISA-Test-Product-Designed-to-Detect-the-Presence-of-the-H-pylori-Bacteria-That-infects-Approximately-35-of-the-U-S-P.html?f=22&fvtc=4&fvtv=37268Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population2023-12-18T12:47:00Z<![CDATA[IRVINE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Hp Detect™ Stool Antigen ELISA test (K232892), a new product that is designed to detect the presence of the H. pylori bacteria, which infects approximately 35% of the U.S. population. H. pylori infection is a disease which affects half the population of the world.]]>https://www.globenewswire.com/news-release/2023/11/10/2778299/0/en/Biomerica-to-Participate-in-14th-Annual-Craig-Hallum-Alpha-Select-Conference-on-November-16.html?f=22&fvtc=4&fvtv=37268Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 162023-11-10T13:19:00Z<![CDATA[IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023, at the Sheraton New York Times Square Hotel in New York City. Zackary Irani, Chief Executive Officer of Biomerica will be hosting meetings during the event, which consists of one-on-one and small group meetings.]]>https://www.globenewswire.com/news-release/2023/11/08/2776231/0/en/Biomerica-Expands-inFoods-IBS-Reach-with-Addition-of-Several-New-GI-Groups.html?f=22&fvtc=4&fvtv=37268Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups2023-11-08T13:19:00Z<![CDATA[IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that several new Gastrointestinal (GI) groups have signed up and begun using the Company's revolutionary inFoods® IBS Product. This expansion demonstrates growing recognition and adoption of the inFoods IBS test in the medical community, broadening Biomerica's influence in providing innovative solutions for Irritable Bowel Syndrome (IBS) while positioning the Company for product revenue growth over the coming quarters. These new groups join Gastro Health, a group with 390 GI physicians which was the Company's first large physician group customer. In addition, several additional Gastro Health office locations have started using the inFoods IBS therapy for their IBS patients.]]>https://www.globenewswire.com/news-release/2023/10/13/2760118/0/en/REPEAT-Biomerica-Reports-First-Quarter-2024-Financial-Results.html?f=22&fvtc=4&fvtv=37268REPEAT - Biomerica Reports First Quarter 2024 Financial Results2023-10-13T17:10:28Z<![CDATA[IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter of fiscal 2024 ended August 31, 2023.]]>https://www.globenewswire.com/news-release/2023/10/13/2759856/0/en/Biomerica-Reports-First-Quarter-2024-Financial-Results.html?f=22&fvtc=4&fvtv=37268Biomerica Reports First Quarter 2024 Financial Results2023-10-13T10:39:00Z<![CDATA[IRVINE, Calif., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical diagnostic and therapeutic products today reported financial results for the first quarter of fiscal 2024 ended August 31, 2023.]]>https://www.globenewswire.com/news-release/2023/09/26/2749488/0/en/Dubai-Government-Grants-Insurance-Reimbursement-for-Biomerica-s-EZ-Detect-Colorectal-Disease-Screening-Test.html?f=22&fvtc=4&fvtv=37268Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test2023-09-26T12:19:00Z<![CDATA[Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide Simple 2 minute at-home test detects an early warning sign of colorectal cancer, the third most common cancer worldwide]]>